Home>Topics>Regions>North America

North America

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
  1. MacroGenics cancer drug trial approval triggers milestone payment

    Headlines

    Fri, 25 Jul 2014

    French pharmaceutical firm Servier. Servier has an option to secure an exclusive license to MGD007 for all territories except North America , Japan, Korea and India. It may exercise its option upon the completion of the Phase 1 trial which is slated to begin

  2. More on Stanley Black & Decker's Q2

    Headlines

    Fri, 25 Jul 2014

    13.5%. Organic growth was negatively impacted by unusually weak emerging markets as well as a delayed and shortened North American outdoor product season. These factors muted organic growth by two points. The company boosted its forecast for adjusted

  3. Sell-side weighs in on GM

    Headlines

    Fri, 25 Jul 2014

    noting better-than-forecast results in South America and Asia. The team also notes management's confidence for better North American pricing ahead in H2. Goldman maintains GM as a Conviction Buy. Shares -0.75% premarket Earnings coverage Post your

  4. Luxottica Shows Improvement in Growth and Profitability; Shares Still Above Fair Value

    Commentary

    Fri, 25 Jul 2014

    6.2% growth reported). Retail grew only 4.3% in constant terms, but lost 1.1% on a reported basis as the North American optical segment’s flat sales offset positive comparable store sales of 8.5% at Sunglass Hut. The lower percentage

  5. Centrica to Exit No-Moat Home Services Business in Ontario

    Commentary

    Fri, 25 Jul 2014

    Centrica announced that its North American subsidiary Direct Energy has agreed to sell its Ontario home services business to EnerCare ..... Centrica to exit Ontario, a region no longer a material part of Centrica's business in North America .

  6. New Morningstar Analyst Report for Informatica Corp

    Stock Reports

    Fri, 25 Jul 2014

    2014 price/earnings ratio of 20 times. The decrease in our fair value estimate is the result of modestly weaker demand in North America . We believe management has sorted out the salesforce difficulties, but it will take a few quarters to build out the new

  7. Interim Results Justify Pearson's Strategy; Shares Are an Opportunity for Long-Term Investors

    Commentary

    Fri, 25 Jul 2014

    structure, Pearson reported modest underlying growth in North America , partially helped by timing issues around second semester ..... markets versus developed markets. In the counter-cyclical North American market, for example, higher education enrollments declined

  8. Abaxis' (ABAX) CEO Clint Severson on Q1 2015 Results - Earnings Call Transcript

    Headlines

    Thu, 24 Jul 2014

    Al Santa Ines - CFO Donald Wood – COO Craig Tockman - Director of Field Operations, North American Animal Health Rick Betts - Director of North American Medical Sales and Marketing Analysts Jim Sidoti - Sidoti & Company Ross Taylor - C.L

  9. Amazon now -10.3% AH; CC touches on losses, AWS, video spend

    Headlines

    Thu, 24 Jul 2014

    Services' near-term growth has been hurt by an ongoing cloud infrastructure price war with Microsoft and Google - while North American "Other" revenue was up 38% Y/Y, it fell 3% Q/Q, and Y/Y growth decelerated from Q1's 60%. He also suggests

  10. Axiron Sales Back on Track; New Acrux CEO announced: Fair Value Unchanged

    Commentary

    Thu, 24 Jul 2014

    Communication, or DSC, issued by the U.S. Food and Drug Administration, or FDA, on 31 January 2014 on uptake of the product in North America . Notably, the FDA’s investigation of adverse events reported among men taking FDA-approved testosterone products

« Prev12345Next »
Content Partners